What changed
2026-07-28 09:14 UTC → 2026-07-30 16:19 UTC ·
added
removed
July 2026 analyses of the Framingham Heart Study consistently showed Recent updates reinforce earlier findings that nightly sleep exceeding 8½ hours is associated with elevated higher blood levels of phosphorylated tau‑181 (p‑tau181), an early Alzheimer’s disease biomarker. The relationship intensified for biomarker, with the strongest elevations observed in participants reporting around ten 10 hours or more, reinforcing earlier observations of a J‑shaped risk curve for long sleep. more. A new meta‑analysis of 57 structural neuroimaging studies added a neuroanatomical dimension, identifying confirms reduced gray‑matter volume in the thalamic pulvinar across various sleep‑disorder cohorts groups and thinner adds that parasomnia cohorts also show thinning of the posterior cingulate cortex in parasomnia groups. These findings suggest that cortex, underscoring distinct neuroanatomical signatures of prolonged or disturbed sleep. Separate research on a British birth cohort links chronic financial hardship to accelerated brain ageing, manifested as greater atrophy and poorer cognitive performance. While this socioeconomic line of inquiry is unrelated to sleep may correspond with specific brain‑structure alterations duration, it highlights additional pathways that coexist with biomarker elevations. may converge on neurodegeneration. Both lines of evidence avenues remain cross‑sectional, precluding causal inference. Researchers stress the need for observational; longitudinal work to determine whether extended sleep reflects early neurodegenerative changes, contributes to them, or both, and is needed to clarify mechanisms linking sleep duration, causal directions between sleep, brain morphology, structure, socioeconomic factors, and Alzheimer‑related pathology.